EP3419661A4 - Method and composition for treating cancer or skin lesion using a vaccine - Google Patents
Method and composition for treating cancer or skin lesion using a vaccine Download PDFInfo
- Publication number
- EP3419661A4 EP3419661A4 EP17757336.7A EP17757336A EP3419661A4 EP 3419661 A4 EP3419661 A4 EP 3419661A4 EP 17757336 A EP17757336 A EP 17757336A EP 3419661 A4 EP3419661 A4 EP 3419661A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- vaccine
- composition
- treating cancer
- skin lesion
- lesion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662300785P | 2016-02-27 | 2016-02-27 | |
US201662328487P | 2016-04-27 | 2016-04-27 | |
US201662338183P | 2016-05-18 | 2016-05-18 | |
US201762444576P | 2017-01-10 | 2017-01-10 | |
US201762455434P | 2017-02-06 | 2017-02-06 | |
PCT/US2017/019433 WO2017147475A1 (en) | 2016-02-27 | 2017-02-24 | Method and composition for treating cancer or skin lesion using a vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3419661A1 EP3419661A1 (en) | 2019-01-02 |
EP3419661A4 true EP3419661A4 (en) | 2019-10-23 |
Family
ID=59686556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17757336.7A Pending EP3419661A4 (en) | 2016-02-27 | 2017-02-24 | Method and composition for treating cancer or skin lesion using a vaccine |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP3419661A4 (en) |
JP (3) | JP2019506435A (en) |
KR (1) | KR20180112043A (en) |
CN (1) | CN108883168A (en) |
AU (1) | AU2017223970B2 (en) |
BR (1) | BR112018067550A2 (en) |
CA (1) | CA3015519A1 (en) |
CL (1) | CL2018002438A1 (en) |
CO (1) | CO2018009205A2 (en) |
HK (1) | HK1256935A1 (en) |
IL (1) | IL261340B2 (en) |
MX (1) | MX2018010338A (en) |
MY (1) | MY194694A (en) |
SG (1) | SG11201807080UA (en) |
WO (1) | WO2017147475A1 (en) |
ZA (1) | ZA201805679B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021013069A1 (en) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | Chimeric human papillomavirus type 11 l1 protein |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002087614A2 (en) * | 2001-04-27 | 2002-11-07 | Glaxosmithkline Biologicals S.A. | Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
WO2003078455A2 (en) * | 2002-03-18 | 2003-09-25 | Glaxosmithkline Biologicals Sa | Virus like particle from papillomavirus and their use in vaccine |
WO2003077942A2 (en) * | 2002-03-18 | 2003-09-25 | Glaxosmithkline Biologicals Sa | Virus-like particles of human papillomavirus |
WO2010120266A1 (en) * | 2009-04-13 | 2010-10-21 | Inserm, Institut National De La Sante Et De La Recherche Medicale | Hpv particles and uses thereof |
US20130064849A1 (en) * | 2011-07-14 | 2013-03-14 | The Board Of Regents Of The University Of Texas | Methods to treat and prevent cardiovascular disease using human papillomavirus vaccines |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890160B (en) * | 2009-04-28 | 2014-06-18 | 北京康乐卫士生物技术有限公司 | Multivalent recombinant human papilloma virus vaccine and application thereof |
US20120087937A1 (en) * | 2009-06-25 | 2012-04-12 | Brigitte Desiree Alberte Colau | Novel compositions |
JP2014516075A (en) * | 2011-06-06 | 2014-07-07 | シェブロン フィリップス ケミカル カンパニー エルピー | Use of metallocene compounds for the treatment of cancer |
BR112014023092A8 (en) * | 2012-03-18 | 2017-07-25 | Glaxosmithkline Biologicals Sa | IMMUNOGENIC COMPOSITION, METHOD FOR THE PREVENTION OF INFECTION OR DISEASE BY HPV IN AN INDIVIDUAL, AND, KIT |
US20130251782A1 (en) * | 2012-03-22 | 2013-09-26 | Leo Laboratories Limited | Topical application of ingenol mebutate with occlusion |
US20140275082A1 (en) * | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
CA2927126A1 (en) * | 2013-10-13 | 2015-04-16 | The Board Of Trustees Of The University Of Arkansas | Human papilloma virus therapeutic vaccine |
JP7037884B2 (en) * | 2014-01-13 | 2022-03-17 | ベイラー リサーチ インスティテュート | New vaccines for HPV and HPV-related diseases |
AU2015335652B2 (en) * | 2014-10-24 | 2020-07-02 | Hpvvax, Llc. | Cancer and skin lesion treatment |
-
2017
- 2017-02-24 BR BR112018067550A patent/BR112018067550A2/en unknown
- 2017-02-24 MY MYPI2018001489A patent/MY194694A/en unknown
- 2017-02-24 SG SG11201807080UA patent/SG11201807080UA/en unknown
- 2017-02-24 CN CN201780016785.3A patent/CN108883168A/en active Pending
- 2017-02-24 EP EP17757336.7A patent/EP3419661A4/en active Pending
- 2017-02-24 CA CA3015519A patent/CA3015519A1/en active Pending
- 2017-02-24 CO CONC2018/0009205A patent/CO2018009205A2/en unknown
- 2017-02-24 JP JP2018544832A patent/JP2019506435A/en active Pending
- 2017-02-24 KR KR1020187027123A patent/KR20180112043A/en unknown
- 2017-02-24 WO PCT/US2017/019433 patent/WO2017147475A1/en active Application Filing
- 2017-02-24 MX MX2018010338A patent/MX2018010338A/en unknown
- 2017-02-24 AU AU2017223970A patent/AU2017223970B2/en active Active
-
2018
- 2018-08-23 IL IL261340A patent/IL261340B2/en unknown
- 2018-08-24 ZA ZA201805679A patent/ZA201805679B/en unknown
- 2018-08-24 CL CL2018002438A patent/CL2018002438A1/en unknown
- 2018-12-13 HK HK18116062.9A patent/HK1256935A1/en unknown
-
2021
- 2021-06-30 JP JP2021108667A patent/JP2021155448A/en active Pending
-
2023
- 2023-06-05 JP JP2023092142A patent/JP2023110038A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002087614A2 (en) * | 2001-04-27 | 2002-11-07 | Glaxosmithkline Biologicals S.A. | Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
WO2003078455A2 (en) * | 2002-03-18 | 2003-09-25 | Glaxosmithkline Biologicals Sa | Virus like particle from papillomavirus and their use in vaccine |
WO2003077942A2 (en) * | 2002-03-18 | 2003-09-25 | Glaxosmithkline Biologicals Sa | Virus-like particles of human papillomavirus |
WO2010120266A1 (en) * | 2009-04-13 | 2010-10-21 | Inserm, Institut National De La Sante Et De La Recherche Medicale | Hpv particles and uses thereof |
US20130064849A1 (en) * | 2011-07-14 | 2013-03-14 | The Board Of Regents Of The University Of Texas | Methods to treat and prevent cardiovascular disease using human papillomavirus vaccines |
Non-Patent Citations (4)
Title |
---|
A. SCHILLING ET AL: "Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines", PEDIATRICS, vol. 136, no. 3, 1 September 2015 (2015-09-01), pages e563 - e572, XP055519294, ISSN: 0031-4005, DOI: 10.1542/peds.2014-4199 * |
ANNA J. NICHOLS ET AL: "Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas", JAMA DERMATOLOGY, vol. 154, no. 8, 1 August 2018 (2018-08-01), US, pages 927, XP055537673, ISSN: 2168-6068, DOI: 10.1001/jamadermatol.2018.1748 * |
ANNA TADDIO ET AL: "A randomized controlled trial of analgesia during vaccination in adults", VACCINE, vol. 28, no. 32, 1 July 2010 (2010-07-01), AMSTERDAM, NL, pages 5365 - 5369, XP055620773, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2010.05.015 * |
GARLAND SUZANNE M ET AL: "Safety and immunogenicity of a 9-valent HPV vaccine in females 12-26 years of age who previously received the quadrivalent HPV vaccine", VACCINE, vol. 33, no. 48, 3 August 2015 (2015-08-03), pages 6855 - 6864, XP029332047, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2015.08.059 * |
Also Published As
Publication number | Publication date |
---|---|
CA3015519A1 (en) | 2017-08-31 |
KR20180112043A (en) | 2018-10-11 |
BR112018067550A2 (en) | 2019-10-01 |
MY194694A (en) | 2022-12-15 |
EP3419661A1 (en) | 2019-01-02 |
CL2018002438A1 (en) | 2019-01-04 |
SG11201807080UA (en) | 2018-09-27 |
AU2017223970A1 (en) | 2018-09-13 |
ZA201805679B (en) | 2019-11-27 |
IL261340B2 (en) | 2023-07-01 |
AU2017223970B2 (en) | 2022-01-27 |
CO2018009205A2 (en) | 2018-09-20 |
MX2018010338A (en) | 2018-11-09 |
WO2017147475A1 (en) | 2017-08-31 |
JP2023110038A (en) | 2023-08-08 |
CN108883168A (en) | 2018-11-23 |
HK1256935A1 (en) | 2019-10-04 |
JP2021155448A (en) | 2021-10-07 |
IL261340B1 (en) | 2023-03-01 |
IL261340A (en) | 2018-11-29 |
JP2019506435A (en) | 2019-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3551100A4 (en) | Medical devices for treating hard tissues and related methods | |
EP3634442A4 (en) | Methods for treating and preventing diseases | |
EP3160566A4 (en) | Tissue sampling and cancer treatment methods and apparatus | |
EP3518783A4 (en) | Apparatus and methods for tissue reduction | |
EP3277166A4 (en) | Method and apparatus for treating soft tissue injury | |
EP3538119A4 (en) | Compositions and methods for treating skin diseases and maintaining healthy skin | |
EP3347025A4 (en) | Methods and compositions for cancer treatment | |
EP3445265A4 (en) | Skin treatment apparatus and method | |
EP3391901A4 (en) | Method for preventing or treating liver tissue damage and associated diseases | |
EP3589659A4 (en) | Compounds and methods for treating cancer | |
EP3568195A4 (en) | Systems and methods for musculoskeletal tissue treatment | |
EP3554310A4 (en) | Packaged skin treatment composition and method | |
EP3556380A4 (en) | Method for preventing and treating tissue and organ fibrosis | |
EP3411122A4 (en) | Cancer vaccines and methods of treatment using the same | |
EP3407961A4 (en) | Skin treatment apparatus and method | |
EP3352729A4 (en) | Method and compositions for treating skin | |
EP3688023A4 (en) | Methods and compositions for cancer treatment | |
EP3697767A4 (en) | Compounds and methods for treating cancer | |
EP3455761A4 (en) | Methods and materials for staging and treating skin cancer | |
EP3677267A4 (en) | Pharmaceutical composition for tumor treatment or prevention, method, and use thereof | |
EP3443090A4 (en) | Use of mir-223-3p as a cancer therapeutic and method for treating cancer using the same | |
EP3576761A4 (en) | Herbo-mineral formulation for the treatment of cancer and method of preparation thereof | |
HK1256935A1 (en) | Method and composition for treating cancer or skin lesion using a vaccine | |
ZA201904626B (en) | Cancer treatment method and composition | |
EP3703653A4 (en) | Compositions and methods for cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180822 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190925 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/12 20060101AFI20190919BHEP Ipc: A61P 35/00 20060101ALI20190919BHEP Ipc: C12N 7/00 20060101ALI20190919BHEP Ipc: C07K 14/005 20060101ALI20190919BHEP Ipc: A61P 31/20 20060101ALI20190919BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20201028 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |